跳至主要内容
临床试验/NCT00759668
NCT00759668已完成不适用

Visual Function and Patient Satisfaction After Bilateral Implantation of AcrySof Natural ReSTOR (Model SN60D3) or AcrySof Natural Monofocal (Model SN60AT)

Alcon Research1 个研究点 分布在 1 个国家目标入组 35 人开始时间: 2007年5月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
35
试验地点
1
主要终点
Near Uncorrected Visual Acuity (UCVA) Binocular

研究概览

简要总结

The purpose of the study is:

  • to compare visual parameters (Subjective refraction and Visual Acuity (VA)) and safety (tilt, decentration and posterior chamber opacification (PCO)) in a prospective series of 40 patients after bilateral implantation of AcrySof Natural ReSTOR (Model SN60D3) or AcrySof Natural Monofocal (Model SN60AT)
  • to assess patient satisfaction before and after implant

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
50 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Written informed consent
  • •Age: ≥ 50 years ≤ 75 years
  • •Bilateral age related cataract, to be extracted and followed by the implantation of Posterior Chamber Intraocular Lenses (IOLs)
  • •Pre-operative and post-operative astigmatism ≤ 1 Diopter (D), as from Keratometry readings
  • •Potential post operative Visual Acuity (VA) ≥ 20/40
  • •Second eye surgery to take place no longer than 45 days after the first implant

排除标准

  • •Irregular optical aberrations;
  • •Pupil diameter in scotopic conditions more than 6 mm
  • •Degenerative visual pathologies (ex: Age-related Macular Degeneration (AMD))
  • •Other exclusions as from ReSTOR Directions for Use (DFU)

研究组 & 干预措施

SN60D3

Experimental

AcrySof Natural ReSTOR Intraocular Lens (IOL) Model SN60D3

干预措施: Acrysof Natural ReSTOR SN60D3 (Device)

SN60AT

Active Comparator

AcrySof Natural Monofocal Intraocular Lens (IOL) Model SN60AT

干预措施: Acrysof Natural Monofocal SN60AT (Device)

结局指标

主要结局

Near Uncorrected Visual Acuity (UCVA) Binocular

时间窗: 6 months after second eye implantation

Percentage of patients with Near Visual Acuity (VA) ≥ 6.5/10 (≤ 0.18 LogMAR) at visit 8 (six months after implantation of the 2nd eye). This test was conducted binocularly and with no correction. The effect of treatment was tested by Chi-square test. VA is acuteness or clearness of vision, which is dependent on the sharpness of the retinal focus within the eye and the sensitivity of the interpretative faculty of the brain. VA is measured in logMAR which is the "logarithm of the minimum angle of resolution". A lower logMAR value indicates better VA.

Near Uncorrected Visual Acuity Right Eye (UCVA RE)

时间窗: 6 months after second eye implantation

Percentage of patients with Near Visual Acuity (VA) ≥ 6.5/10 (≤ 0.18 LogMAR) at visit 8 (six months after implantation of the 2nd eye). This test was conducted monocularly (right eye only) and with no correction. The effect of treatment was tested by Chi-square test. VA is acuteness or clearness of vision, which is dependent on the sharpness of the retinal focus within the eye and the sensitivity of the interpretative faculty of the brain. VA is measured in logMAR which is the "logarithm of the minimum angle of resolution". A lower logMAR value indicates better VA.

Near Best Corrected Visual Acuity (BCVA) - Binocular

时间窗: 6 months after second eye implantation

Percentage of patients with Near Visual Acuity (VA) ≥ 6.5/10 (≤ 0.18 LogMAR) at visit 8 (six months after implantation of the 2nd eye). This test was conducted binocularly and with best correction. The effect of treatment was tested by Chi-square test. VA is acuteness or clearness of vision, which is dependent on the sharpness of the retinal focus within the eye and the sensitivity of the interpretative faculty of the brain. VA is measured in logMAR which is the "logarithm of the minimum angle of resolution". A lower logMAR value indicates better VA.

Near Best Corrected Visual Acuity Left Eye (BCVA LE)

时间窗: 6 months after second eye implantation

Percentage of patients with Near Visual Acuity (VA) ≥ 6.5/10 (≤ 0.18 LogMAR) at visit 8 (six months after implantation of the 2nd eye). This test was conducted monocularly (left eye only) and with best correction. The effect of treatment was tested by Chi-square test. VA is acuteness or clearness of vision, which is dependent on the sharpness of the retinal focus within the eye and the sensitivity of the interpretative faculty of the brain. VA is measured in logMAR which is the "logarithm of the minimum angle of resolution". A lower logMAR value indicates better VA.

Near Uncorrected Visual Acuity Left Eye (UCVA LE)

时间窗: 6 months after second eye implantation

Percentage of patients with Near Visual Acuity (VA) ≥ 6.5/10 (≤ 0.18 LogMAR) at visit 8 (six months after implantation of the 2nd eye). This test was conducted monocularly (left eye only) and with no correction. The effect of treatment was tested by Chi-square test. VA is acuteness or clearness of vision, which is dependent on the sharpness of the retinal focus within the eye and the sensitivity of the interpretative faculty of the brain. VA is measured in logMAR which is the "logarithm of the minimum angle of resolution". A lower logMAR value indicates better VA.

Near Best Corrected Visual Acuity Right Eye (BCVA RE)

时间窗: 6 months after second eye implantation

Percentage of patients with Near Visual Acuity (VA) ≥ 6.5/10 (≤ 0.18 LogMAR) at visit 8 (six months after implantation of the 2nd eye). This test was conducted monocularly (right eye only) and with best correction. The effect of treatment was tested by Chi-square test. VA is acuteness or clearness of vision, which is dependent on the sharpness of the retinal focus within the eye and the sensitivity of the interpretative faculty of the brain. VA is measured in logMAR which is the "logarithm of the minimum angle of resolution". A lower logMAR value indicates better VA.

次要结局

未报告次要终点

研究者

申办方类型
Industry

研究点 (1)

Loading locations...

相似试验